CWM
AMGN icon

Calamos Wealth Management’s Amgen AMGN Stock Holding History

Calamos Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Sell
2,408
-3,340
-58% -$1.14M 0.03% 233
2026
Q1 		$2.02M Sell
5,748
-53
-0.9% -$18.9K 0.07% 143
2025
Q4 		$1.9M Sell
5,801
-12
-0.2% -$3.81K 0.07% 134
2025
Q3 		$1.64M Buy
5,813
+3,351
+136% +$972K 0.06% 146
2025
Q2 		$687K Sell
2,462
-116
-4% -$32.9K 0.03% 208
2025
Q1 		$803K Buy
2,578
+119
+5% +$35.1K 0.04% 170
2024
Q4 		$641K Buy
2,459
+54
+2% +$16K 0.03% 194
2024
Q3 		$775K Buy
2,405
+538
+29% +$176K 0.04% 176
2024
Q2 		$583K Sell
1,867
-29
-2% -$8.52K 0.03% 190
2024
Q1 		$539K Sell
1,896
-75
-4% -$21.9K 0.03% 199
2023
Q4 		$568K Buy
1,971
+6
+0.3% +$1.64K 0.04% 184
2023
Q3 		$528K Buy
1,965
+198
+11% +$49.4K 0.04% 198
2023
Q2 		$392K Sell
1,767
-33
-2% -$7.66K 0.03% 222
2023
Q1 		$435K Sell
1,800
-22
-1% -$5.4K 0.03% 217
2022
Q4 		$479K Buy
1,822
+39
+2% +$10.5K 0.04% 203
2022
Q3 		$402K Hold
1,783
– – 0.03% 217
2022
Q2 		$434K Sell
1,783
-90
-5% -$22.1K 0.04% 210
2022
Q1 		$453K Sell
1,873
-1,425
-43% -$327K 0.03% 230
2021
Q4 		$742K Sell
3,298
-1,756
-35% -$371K 0.05% 189
2021
Q3 		$1.07M Sell
5,054
-400
-7% -$92.1K 0.09% 155
2021
Q2 		$1.33M Buy
5,454
+1,262
+30% +$310K 0.1% 137
2021
Q1 		$1.04M Buy
4,192
+171
+4% +$40.8K 0.09% 155
2020
Q4 		$925K Sell
4,021
-1,147
-22% -$264K 0.08% 152
2020
Q3 		$1.31M Sell
5,168
-75
-1% -$18.6K 0.15% 93
2020
Q2 		$1.24M Buy
5,243
+1,005
+24% +$229K 0.15% 93
2020
Q1 		$859K Buy
4,238
+563
+15% +$123K 0.13% 107
2019
Q4 		$886K Sell
3,675
-27
-0.7% -$5.95K 0.1% 128
2019
Q3 		$716K Buy
3,702
+2,181
+143% +$419K 0.1% 144
2019
Q2 		$280K Buy
1,521
+195
+15% +$34.9K 0.04% 200
2019
Q1 		$252K Hold
1,326
– – 0.04% 198
2018
Q4 		$258K Hold
1,326
– – 0.04% 193
2018
Q3 		$275K Sell
1,326
-2,659
-67% -$524K 0.03% 188
2018
Q2 		$736K Sell
3,985
-74
-2% -$13.1K 0.09% 127
2018
Q1 		$692K Sell
4,059
-15,221
-79% -$2.79M 0.09% 135
2017
Q4 		$3.35M Buy
+19,280
New +$3.41M 0.44% 69
2017
Q3 		– Sell
-9,411
Closed -$1.62M – 225
2017
Q2 		$1.62M Buy
9,411
+8,035
+584% +$1.31M 0.23% 109
2017
Q1 		$226K Buy
+1,376
New +$229K 0.03% 202
2016
Q4 		– Sell
-1,326
Closed -$221K – 222
2016
Q3 		$221K Hold
1,326
– – 0.04% 186
2016
Q2 		$202K Buy
+1,326
New +$206K 0.04% 212
2016
Q1 		– Sell
-1,326
Closed -$215K – 243
2015
Q4 		$215K Buy
+1,326
New +$208K 0.04% 232

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Calamos Wealth Management's AMGN Position: Q2 2026 in Review

Calamos Wealth Management reduced its Amgen (AMGN) stake by 58% in Q2 2026, selling an estimated $1.14M and leaving 2,408 shares worth $872K. The position accounts for 0.03% of the portfolio, ranked #233.

Calamos Wealth Management first reported a position in AMGN in Q4 2015 and has held it in 40 quarters since. The position peaked at $3.35M in Q4 2017. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Calamos Wealth Management held 2,408 shares of Amgen worth $872K as of Q2 2026.
  • Calamos Wealth Management sold 3,340 Amgen shares in Q2 2026, an estimated $1.14M.
  • Amgen made up 0.03% of Calamos Wealth Management's portfolio in Q2 2026, its #233 holding.
  • Calamos Wealth Management first reported a position in Amgen in Q4 2015 and has held it in 40 quarters since.
  • Calamos Wealth Management's Amgen position peaked at $3.35M in Q4 2017.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.